Surgical intervention for aortic aneurysms follows well-established diameter criteria: elective surgery is generally recommended when an abdominal aortic aneurysm reaches 5 cm in diameter or a thoracic aortic aneurysm reaches 5.5 cm. Even smaller aneurysms exhibiting rapid growth also warrant timely intervention. Patients experiencing symptoms such as vague abdominal pain or chest tightness/pain should seek medical evaluation promptly.

For adult cardiopulmonary resuscitation (CPR), the standard chest compression depth is 5–6 cm. This depth ensures effective chest recoil and adequate cardiac output, thereby meeting the blood supply requirements of vital organs. Compressions that are too shallow fail to generate effective circulation, while excessive depth may cause injury to the chest wall tissues. In cases of sudden cardiac arrest, immediate CPR should be initiated, followed by prompt medical attention.

Su Xiao Xiu Xin Wan cannot replace nitroglycerin. Both medications can be used for angina pectoris attacks, but they differ in active ingredients, onset of action, and appropriate clinical scenarios. Nitroglycerin has a faster onset of action and is the first-line drug for acute angina attacks. If chest pain persists without relief and is accompanied by profuse sweating, prompt medical attention is required.

Hypertrophic cardiomyopathy (HCM) is a clearly hereditary cardiac disorder inherited in an autosomal dominant pattern; affected family members can pass the disease-causing gene to their offspring. Some offspring carry the gene but never develop symptoms throughout their lives, while others may manifest the disease during adolescence or middle age. Individuals with a family history of heart disease—or young people experiencing palpitations and chest tightness—should seek timely medical evaluation and screening.

Dilated cardiomyopathy cannot be completely cured and is a chronic, progressive heart disease characterized by irreversible enlargement and damage to the heart’s structure. Clinical management focuses on halting disease progression, improving cardiac function, and enhancing quality of life. Patients experiencing symptoms such as chest tightness, shortness of breath, or lower-limb edema should seek timely medical evaluation and intervention.

Most patients with myocarditis recover fully without any long-term complications. In mild cases, myocardial inflammation is transient, and with appropriate rest and treatment, the myocardial tissue can heal completely. However, patients with severe myocarditis or those who do not recover well may develop persistent arrhythmias or impaired cardiac function. Recurrent palpitations or fatigue during the recovery period warrant prompt medical evaluation.

There is no absolute, fixed numerical threshold for premature cardiac contractions (PCCs) that universally warrants concern. Clinical assessment must consider the type of PCCs, underlying cardiac structure and function, and associated symptoms. For instance, several thousand PCCs per day without symptoms—and with a structurally normal heart—may only require routine follow-up. Conversely, even a small number of PCCs accompanied by chest tightness or presyncope should raise clinical suspicion. Persistent palpitations or chest pain necessitate prompt medical evaluation.

Not all arrhythmias require radiofrequency ablation therapy. Clinically, the choice of intervention depends on the type of arrhythmia, frequency of episodes, and severity of symptoms. Mild, infrequent arrhythmias may be managed conservatively. In contrast, persistent, refractory arrhythmias are suitable candidates for radiofrequency ablation. If heart rate remains persistently irregular—especially when accompanied by chest tightness or dizziness—prompt medical evaluation is essential.

Not all patients with atrial fibrillation require long-term anticoagulant therapy; the decision to initiate treatment depends on an individual’s thrombotic risk level. Patients at low risk do not require anticoagulation, whereas those at moderate-to-high risk need long-term, standardized anticoagulant therapy to reduce the risk of thrombus formation and stroke. Prompt medical evaluation is essential if symptoms such as limb numbness or speech abnormalities occur.

Statins may affect liver function, but the risk of liver injury is low. Most individuals who take these medications as prescribed will not experience hepatic abnormalities. Statins are primarily used to regulate blood lipid levels and stabilize atherosclerotic plaques in blood vessels; therefore, routine monitoring of liver function during treatment is sufficient. If symptoms such as fatigue or loss of appetite occur, prompt medical evaluation is recommended.